FRACIA WILL PUT PFIZER OR MODERN THOSE WHO RECEIVED THE FIRST DOSE OF ASTRAZENECA
France inject a second dose of Pfizer or Moderna vaccines to patients under the age of 55 who have already received a first dose of AstraZeneca, after having recommended not to inject this to that age group due to the risks of suffering from thrombi.
The French Minister of Health, Olivier Véran, declared this Friday on RTL radio that that will be the solution that the High Health Authority will adopt (HAS, French acronym), for the second dose of the 500,000 people, for the most part sanitary, of that age group vaccinated with a dose of AstraZeneca.
That body, in charge of authorizing all medicines in the country, On March 19, it suspended injections with the British-Swedish vaccine for those under 55 years of age, after the appearance of some cases of thrombi in people who received it in Europe.
“It is consistent to say that the vaccine is not recommended for those under 55 years of age, but if they have received a first dose, we are going to propose another RNA vaccine. I myself am part of that group. They will receive a second dose within the deadlines, “said Véran, who pointed out that the official announcement corresponds to the HAS, an independent authority.
The head of the Infectious Diseases service at the Henri Mondor de Créteil hospital, on the outskirts of Paris, Jean-Daniel Lelièvre, a member of the HAS, confirmed this information on the France Info station. He explained that They are not considering giving a second dose of AstraZeneca to those citizens and that combining vaccines can have positive effects.
“A single dose is not enough to guarantee long-term immunity against covid … We have decided to use one of the RNA vaccines,” that is, those from Pfizer and Moderna, he said. For the expert, although the AstraZeneca vaccine and the RNA vaccines have different techniques, “they lead to the production of the same protein”, which is responsible for generating immunity.
The expert recalled that this type of strategy is already used in the fight against other diseases, such as AIDS or Ebola.
–
